{'Year': '2013', 'Month': 'Jul'}
Genetics-based pediatric warfarin dosage regimen derived using pharmacometric bridging.
Warfarin dosage regimens using CYP2C9 and VKORC1 polymorphisms have been extensively studied in adults and is included in US Food and Drug Administration-approved warfarin labeling. However, no dosage algorithm is available for pediatric patients.